Login
Toggle navigation
Videos
Categories
Trending
CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Nicolaas Vlok | CEO - MeridianLink, Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Livingbridge Partner Wol Kolade on Strategic Growth and Industry Leadership | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Burry Creek Gold Project: Yukon's Premier First World Jurisdiction Investment Opportunity
00:10:00
AI in Travel: Jane Sun on Transforming the Industry at Trip.com | Morgan Stanley
00:00:00
BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl
00:10:00
Carson Block, founder of Muddy Waters Research, joins 'Closing Bell' to explain why his firm began investigating Hannon Armstrong's financial practices.
00:10:00
China's Economic Recovery and Its Impact on Metals Price
00:10:00
Previewing the 2023 Rule Symposium: CEO Ross McElroy of Fission Uranium Corp and John Ciampaglia from Sprott Inc. discuss industry insights with Rick Rule.
00:00:00
Richard C. Daly, M.D. Cardiovascular Surgeon, Mayo Clinic
00:10:00
Catalyst Metals Targets 200K Oz Annual Gold Production with Strategic Acquisitions
00:10:00
Tesoro Gold: Advancing Chilean Gold Projects
00:10:00
The Virtual Loadmaster Training System (VLTS) by Pennant International Group plc offers advanced virtual training solutions for loadmaster operations.
00:10:00
BigCommerce CEO Brent Bellm appears on "Squawk Alley" ahead of the company's public debut.|Brent is the Chief Executive Officer of BigCommerce.